12:00 AM
 | 
Mar 11, 2004
 |  BC Extra  |  Clinical News

Enzo Alequel Phase II data

ENZ said that in an ongoing, double-blind Israeli Phase II study in Crohn's disease patients, 5 of 7 patients receiving its

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >